| (Values in U.S. Thousands) | Aug, 2011 | Aug, 2010 | Aug, 2009 | Aug, 2008 | Aug, 2007 |
| Sales | 96,880 | 90,980 | 50,480 | 78,250 | 116,230 |
| Sales Growth | +6.48% | +80.23% | -35.49% | -32.68% | unch |
| Net Income | 8,320 | 13,020 | -17,620 | -13,630 | -14,580 |
| Net Income Growth | -36.10% | +173.89% | -29.27% | +6.52% | unch |
FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
FS Development Corp. II entered into a definitive business combination agreement with Pardes Biosciences Inc.
Fiscal Year End Date: 08/31